Endo Presents New Data at the American Podiatric Medical Association Annual Meeting
DUBLIN, July 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that new data from a Phase 1 study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis will be presented during the American Podiatric Medical Association's (APMA) annual scientific meeting.
- DUBLIN, July 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that new data from a Phase 1 study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis will be presented during the American Podiatric Medical Association's (APMA) annual scientific meeting.
- The meeting is taking place now through July 16 in Nashville, Tenn.
- Results from the Phase 1 clinical study showed improvement in nodule hardness and in patient and physician satisfaction scores.
- Endo has completed Phase 2 and anticipates that the pivotal Phase 3 program will begin later this year.